Skip to content

Clinical trials

Liver Cirrhosis, Biliary trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis, Biliary Country / region: Australia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20143
20174
20182
20191
20211
20221
20232
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated5
Recruiting3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Intercept Pharmaceuticals5
Gilead Sciences4
Ipsen2
NGM Biopharmaceuticals, Inc2
Arena Pharmaceuticals1
Calliditas Therapeutics Suisse SA1
Enanta Pharmaceuticals, Inc1
GlaxoSmithKline1
Parvus Therapeutics, Inc.1
Sanford Health1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis, Biliary19
Fibrosis4
Addison Disease1
Alagille Syndrome1
Alstrom Syndrome1
Amnesia, Transient Global1
Aniridia1
Ataxia1
Ataxia Telangiectasia1
Atypical Hemolytic Uremic Syndrome1

Trials

Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.